The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: A comparison to interleukin 1β (IL-1β) and interleukin 1 receptor antagonist (Il-1ra)

Cytokine

Volumn 8, Issue 11, 1996, Pages 820-836

  Brown, Elizabeth A ^a   Dare, Heidi A ^a   Marsh, Clay B ^a   Wewers, Mark D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b N325 Means Hall ^*  (United States)

Author keywords

Dexamethasone; Endotoxin; Interleukin 1; Monocyte; Receptor

Indexed keywords

DEXAMETHASONE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; RECEPTOR SUBTYPE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE INDUCTION; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SEPSIS;

SIPHONAPTERA (FLEAS);

EID: 0030295177     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0111     Document Type: Article

References (40)

1. 1. Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
2. 2. Dower SK, Kronheim CJ, March CJ, Conlon PJ, Hopp TP, Gillis S, Urdal DL (1985) Detection and characterization of high affinity plasma membrane receptors for interleukin-1. J Exp Med 162:501-515.
3. 3. Curtis BM, Gallis B, Overall R, McMahan CJ, de Roos P, Ireland R, Eisenman J, Dower SK, Sims JE (1989) T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1. Proc Natl Acad Sci USA 86:3045-3049.
4. 4. Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Friend D, Alpert AR, Gillis S, Urdal DL, Dower SK (1988) cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:585-589.
5. 5. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein K, Dower SK (1993) Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 90:6155-6159.
6. 6. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821-2832.
7. 7. Colotta R, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
8. 8. Stylianou E, O'Neill LAJ, Rawlinson L, Edbrooke MR, Woo P, Saklatvaka J (1992) Interleukin-1 receptor induces NF-κB through its type I but not its type II receptor in lymphocytes. J Biol Chem 267:15836-15841.
9. 9. Re F, Muzio M, De Rossi M, Polentarutti N, Giri JG, Mantovani A, Colotta F (1994) The type II "receptor" as a decoy target for interleukin-1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 179:739-743.
10. 10. Granowitz EV, Clark BD, Mancilla J, Dinarello CA (1991) Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem 266:14147-14150.
11. 11. Sims JE, Giri JG, Dower SK (1994) The two interleukin-1 receptors play different roles in IL-1 actions. Clin Immunol Immunopathol 72:9-14.
12. 12. Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE, Alderson MR (1994) Elevated levels of shed type II IL-1 receptor in sepsis. J Immunol 153:5802-5809.
13. 13. Alcami A, Smith GL (1992) A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host responses to infection. Cell 71:153-167.
14. 14. Spriggs MK, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller ML, VanSlyke J (1992) Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145-152.
15. 15. Lew W, Oppenheim J, Matsushima K (1988) Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol 140:1895-1902.
16. 16. Kern JA, Lamb, RJ, Reed JC, Daniele RP, Nowell PC (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. J Clin Invest 81:237-244.
17. 17. Symons JA, Duff GW (1990) A soluble form of the interleukin-1 receptor produced by a human B cell line. FEBS 272:133-136.
18. 18. Stoppacciaro A, Bossu P, Ghiara P, Ruco LP, Censini S, Scapiagliati G, Nuti S, Tagliabue A, Baroni CD, Boraschi D (1991) Binding of IL-1β to IL-1R type II at single cell level. J Immunol 147:1561-1566.
19. 19. Spriggs MK, Nevens PJ, Grabstein K, Dower SK, Cosman D, Armitage RJ, McMahan CJ, Sims JE (1992) Molecular characterization of the interleukin-1 receptor (IL-1R) on monocytes and polymorphonuclear cells. Cytokine 4:90-95.
20. 20. Spriggs MK, Lioubin PJ, Slack J, Dower SK, Uwe J, Cosman D, Sims JE, Bauer J (1990) Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. J Biol Chem 265:22499-22505.
21. 21. Arend WP (1991) Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J Clin Invest 88:1445-1451.
22. 22. Arend WP, Welgus HG, Thompson RC, Eisenberg SP (1990) Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85:1694-1697.
23. 23. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA (1991) Production of interleukin-1-receptor antagonist during experimental endotoxemia. Lancet 338:1423-1424.
24. 24. Rogy MA, Coyle SM, Oldenburg HSA, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF (1994) Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 178:132-138.
25. 25. Mancilla J, Garcia P, Dinarello CA (1993) The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats. Infect Immun 61:926-932.
26. 26. Aiura K, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1993) Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits. Infect Immun 61:3342-3350.
27. 27. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1991) A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 5:338-341.
28. 28. Symons JA, Young PR, Duff GW (1995) Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci USA 92:1714-1718.
29. 29. Burger D, Chicheportiche R, Giri JG, Dayer JM (1995) The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest 96:38-41.
30. 30. Constantian MB (1978) Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients. Ann Surg 188:209-215.
31. 31. Richardson RP, Rhyne CD, Fong Y, Hesse DG, Tracey KJ, Marano MA, Lowry SF, Antonacci AC, Calvano SE (1989) Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Ann Surg 210:239-245.
32. 32. Michie HR, Spriggs DR, Manogue KR, Sherman ML, Revhaug A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolff SM, Kufe D, Wilmore DW (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104:280-285.
33. 33. Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shire GT, Lowry SF (1990) Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170:32-38.
34. 34. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer ST, Dinarello CA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486.
35. 35. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer, JWM, Endres S, Lonnemann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Burke JF, Dinarello CA (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79-84.
36. 36. Arzt E, Sauer J, Pollmacher T, Labeur M, Holsboer F, Reul JMHM, Stalla GK (1993) Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 134:672-677.
37. 37. Wewers MD, Herzyk DJ (1989) Alveolar macrophages differ from blood monocytes in human IL-1β release. J Immunol 143:1635-1641.
38. 38. Marsh CB, Wewers MD (1994) Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes. Am J Respir Cell Mol Biol 10:521-525.
39. 39. Altenberger EA, Pope HA, Wewers MD (1995) Detection of the type II interleukin-1 receptor in the presence of its natural ligand IL-1β: quantification by sandwich ELISA. J Immunol Methods 185:115-122.
40. 40. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 277:680-685.